Kymriah™ (tisagenlecleucel, formerly CTL019), the first FDA-approved CAR-T cell therapy, uses CTS Dynabeads CD3/CD28 spherical beads to isolate, activate and expand T cells WALTHAM, Mass. — The U.S. Food and Drug Administration (FDA) has approved a new cell therapy for the treatment of patients up to 25 years of age with B-cell precursor acute lymphoblastic leukemia […]
Recent market developments inspire ExcitePCR management to expand its product strategy to a planned rollout of a FireflyDX family of realtime pathogen detection systems, with the FireflyDX-Portable launch scheduled for the summer of 2018 and the FireflyDX-Handheld targeted for availability in 2019 Pleasanton, Calif. ExcitePCR™ today announced the FireflyDX-Portable™, a rechargeable bookbag-sized realtime pathogen detection […]
Purchase of PMR and creation of Hygiena Mexico establishes permanent base in Mexico City Hygiena, a Warburg Pincus portfolio company that specializes in rapid food safety and environmental sanitation testing, today announced that it has acquired Pruebas Microbiologicas Rapidas (PMR), a Mexico City-based distributor that has long served as an independent partner of Hygiena […]
New Food Safety Studio in Bellevue, Washington, serves as global center for innovation and collaboration Demonstration and training lab space extends product and process development to customers Billerica, Massachusetts — MilliporeSigma has opened its first global Food Safety Studio in Bellevue, Washington for manufacturers of all types of food (beef, poultry, produce, etc.) to collaborate with MilliporeSigma scientists […]
DELRAY BEACH, Fla. — PositiveID Corporation(OTCQB:PSID), a life sciences company focused on detection and diagnostics, today announced that its subsidiary, ExcitePCR Corporation, has hired David L. Politis as its Chief Marketing & Sales Officer. In his role as CMSO, Politis will direct and implement all marketing, sales and business development efforts for ExcitePCR as it prepares […]
Independent new company will accelerate development of Illumina’s forensic genomics technologies to enable more insight than traditional methods SAN DIEGO —- Illumina, Inc. (NASDAQ: ILMN) today announced plans with Telegraph Hill Partners (THP), a San Francisco-based venture capital and growth equity firm, to establish Verogen, Inc. The independent new company has certain exclusive rights to provide Illumina’s forensic sequencing technology to forensic customers, […]
DNAnexus has teamed up with Saphetor, a leading variant analysis company, to build a sample-in, report-out genomic analysis solution. Saphetor annotates and classifies genetic variants from next-generation sequencing (NGS) data to help clinicians quickly and accurately diagnose disease to make faster, more precise treatment decisions. Saphetor’s technology is now available on the DNAnexus cloud-based platform. Saphetor has […]
Seattle, WA – RareCyte, Inc., a global rare cell detection and liquid biopsy company will use the funding to advance its commercial sales efforts and build companion diagnostics (CDx) programs with strategic partners. The Company will also expand its regulatory infrastructure and research and development efforts. The $30M investment was led by 5AM Ventures with participation from […]
Obtain DNA or RNA Extraction in Three Minutes with New Arcis Prep Kit from Cole-Parmer August 23, 2017, Vernon Hills, Illinois – The Arcis Prep Kit, from Cole-Parmer, allows rapid extraction of either DNA or RNA in three minutes with high yields. This process is ideal for any molecular biologist who wants to reduce […]
Notable private equity firm invests £2.5 million in the Cambridge-based biotech Private equity firm Calculus Capital, a leading EIS and VCT investor, has further expanded its life science portfolio, by investing £2.5m in Cambridge-based Axol Bioscience (Axol), a provider of stem cells produced from reprogrammed human blood and tissue cells. Axol supplies the world’s top […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
